Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)

CUSIP: 925050106

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Ordinary Shares, nominal value 0.05 GBP per share
Shares outstanding
84,213,667
Total 13F shares
51,774,348
Share change
+16,935,547
Total reported value
$528,758,643
Put/Call ratio
34%
Price per share
$10.22
Number of holders
65
Value change
+$182,949,663
Number of buys
47
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 925050106?
CUSIP 925050106 identifies VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q3 2022

As of 30 Sep 2022, Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,774,348 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, Fairmount Funds Management LLC, Abingworth LLP, and Frazier Life Sciences Management, L.P.. This page lists 65 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
36
Q3 2022 holders
65
Holder diff
29
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .